J. Robbins

Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria.

J. C. Parke, R. Schneerson, J. Robbins, 1975, The Journal of allergy and clinical immunology.

Hypothesis: how licensed vaccines confer protective immunity.

S. Szu, R. Schneerson, J. Robbins, 1996, Advances in experimental medicine and biology.

Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides.

R. Schneerson, J. Robbins, C. Chu, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bacterial antigens cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b.

J. C. Parke, R. Schneerson, J. Robbins, 1971, Lancet.

Quantitative Measurement of “Natural” and Immunization-induced Haemophilus influenzas type b Capsular Polysaccharide Antibodies

J. C. Parke, R. Schneerson, J. Robbins, 1973, Pediatric Research.

Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model.

J. Battey, J. Robbins, J. Sun, 2000, Vaccine.

Qualitative and quantitative analyses of the antibody response elicited by Haemophilus influenzae type b capsular polysaccharide–tetanus toxoid conjugates in adults with IgG subclass deficiencies and frequent infections

R. Schneerson, J. Robbins, M. Avanzini, 1994, Clinical and experimental immunology.

A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine.

R. Schneerson, J. Robbins, E. Gotschlich, 2000, The Pediatric infectious disease journal.

“Love's labours lost”: failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa

R. Schneerson, J. Robbins, E. Gotschlich, 1997, The Lancet.

Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b.

J. C. Parke, R. Schneerson, J. Robbins, 1971, Journal of immunology.

The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines.

P. Anderson, D. Smith, R. Schneerson, 1996, JAMA.